Opko Health, Inc.OO

Opko Health, Inc.

1.47USDR
−0.01−0.68%
At close at 00:54 UTC
USD
No trades
See on Supercharts

OPK fundamentals

Key facts

Market capitalization‪1.00 B‬USD
Basic EPS (TTM)−0.18USD
Founded1991
Employees (FY)‪3.93 K‬
CEOPhillip Frost
Websiteopko.com
About

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Ownership
‪‪682.48 M‬‬
Closely held shares
‪‪373.26 M‬‬ (54.69%)
Free Float shares
‪‪309.23 M‬‬ (45.31%)
Closely held shares
‪‪373.26 M‬‬ (54.69%)
Free Float shares
‪‪309.23 M‬‬ (45.31%)
Capital structure
Market cap
‪‪1.00 B‬‬
Debt
‪‪512.32 M‬‬
Cash & equivalents
‪‪406.40 M‬‬
Enterprise value
‪‪1.12 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.00 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.08x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.08x
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−48%‬
‪−32%‬
‪−16%‬
‪0%‬
‪16%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−90.00 M‬‬
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−180.00 M‬‬
‪‪−90.00 M‬‬
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Diagnostics
Pharmaceutical
By country
Period: 2023
United States
Ireland
Chile
Spain
Mexico
Israel
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Actual
Estimate
Earnings
Next:Feb 20
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−0.12‬
‪−0.08‬
‪−0.04‬
‪0.00‬
‪0.04‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

OPK does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−200.00 M‬‬
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪450.00 M‬‬
‪‪900.00 M‬‬
‪‪1.35 B‬‬
‪‪1.80 B‬‬
Assets
Liabilities